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Abstract
Introduction. Renal artery stenosis (RAS) is narrowing of
one or both renal arteries or their branches. Clinically sig-
nificant stenosis involves narrowing of the lumen, which is
approximately 80%. The two most common causes of its
occurrence are atherosclerosis and fibromuscular dyspla-
sia. Percutaneous transluminal renal angioplasty (PTRA)
with stent implantation is an effective treatment modality
that leads to lower blood pressure and improvement of
kidney function. Case report. We presented 4 patients
with significant stenosis of one or both renal arteries fol-
lowed by the development of arterial hypertension and re-
nal insufficiency. The causes of RAS were atherosclerosis
in two patients and fibromuscular dysplasia in one patient.
One of the patients  had  renal artery stenosis  of trans-
planted kidney that developed 9 month after transplanta-
tion. In all the patients, in addition to clinical signs, dop-
pler screening suspected the existence of significant renal
artery stenosis. The definitive diagnosis was made by ap-
plying computed tomographic angiography (CTA) of renal
arteries in 3 of the patients and in 1 patient by percutaneus
selective angiography. All the patients were treated by ap-
plication of PTRA with stent implantation followed by
improvement/normalization of blood pressure and kidney
function.  Conclusion. Application of PTRA with stent
implantation is an effective treatment of significant steno-
sis of one or both renal arteries followed by renal insuffi-
ciency.
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Apstrakt
Uvod. Renalna arterijska stenoza (RAS) predstavlja suženje
jedne ili obe renalne arterije ili njihovih grana. Kliniÿki zna-
ÿajna stenoza podrazumeva suženje lumena koje iznosi pribli-
žno 80%, a dva najÿešýa uzroka njenog nastanka su ateroskle-
roza i fibromuskularna displazija. Perkutana transluminalna
renalna angioplastika (PTRA) sa implantacijom stenta, pred-
stavlja efikasan modalitet leÿenja koji dovodi do sniženja krv-
nog pritiska i poboljšanja bubrežne funkcije. Prikaz bolesni-
ka. Prikazali smo ÿetiri bolesnika sa znaÿajnom stenozom je-
dne ili obe renalne arterije, praýene razvojem arterijske hiper-
tenzije i bubrežne insuficijencije. Uzrok nastanka RAS bili su
ateroskleroza kod dva i fibromuskularna displazija kod jednog
bolesnika. Kod jednog bolesnika devet meseci nakon trans-
plantacije bubrega došlo je do razvoja stenoze na mestu ana-
stomoze renalne arterije donorskog bubrega i hipogastriÿne
arterije recipijenta, najverovatnije uzrokovane aterosklero-
zom. Kod sva ÿetiri bolesnika pored kliniÿkih pokazatelja,
doplersonografskim skriningom postavljena je sumnja na po-
stojanje znaÿajne stenoze renalne arterije. Definitivna dijag-
noza postavljena je primenom multislajsne skenerske angio-
grafije renalne arterije kod tri bolesnika, a kod jednog boles-
nika selektivnom angiografijom. Sva ÿetiri bolesnika leÿena su
primenom PTRA sa implantacijom stenta, nakon ÿega je do-
šlo do poboljšanja/normalizacije krvnog pritiska i bubrežne
funkcije. Zakljuÿak. Primena PTRA sa implantacijom stenta
predstavlja efikasan modalitet leÿenja znaÿajne stenoze jedne
ili obe bubrežne arterije, praýene bubrežnom insuficijencijom.
Kljuÿne reÿi:
a. renalis, opstrukcija; bubreg, funkcijski testovi;
dijagnostiÿke tehnike i procedure; angioplastika,
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Introduction
Renal artery stenosis (RAS) is narrowing of one or both
renal arteries or their branches 
1. Clinically significant steno-
sis involves narrowing of the lumen, which is approximately
80%, resulting in renal hypoperfusion, activation of the
renin-angiotensin system, increase in systemic blood pres-
sure and reduction of the glomerular filtration rate 
2, 3. The
two most common causes of RAS are atherosclerosis and fi-
bromuscular dysplasia (FMD). Atherosclerotic renal artery
stenosis (ARAS) is common in adults older than 65 years
with hypertension, generalized atherosclerosis disease and
renal impairment, as the main clinical signs 
4. The reported
prevalence of clinically manifested ARAS in the general
population is 0.5% overall and 5.5% among patients with
chronic kidney disease. Since patients are often asympto-
matic, the actual frequency is higher and ranges up to 7% 
5, 6.
Unlike ARAS, FMD is a nonatherosclerotic and noninflam-
matory vascular disease that most commonly affects the re-
nal and internal carotid arteries but has been described in al-
most every arterial bed in the body, occuring frequently in
young women 
7. Diagnosis of RAS can be set using various
functional and morphological tests 
8. Duplex ultrasonogra-
phy is noninvasive tool which provides a functional assesment
of the severity of stenosis because higher velocity correlates
with a greater pressure differential across the stenosis 
9. Renal
angiography using computed tomography (CTA) or magnetic
resonance (MRA) are noninvasive and sophisticated diag-
nostic techniques. Sensitivity/specificity of these methods is
an average of 64/92% for CTA and 62/84% for MRA 
10. In
patients with chronic kidney disease, the use of CTA and
MRA are limited by toxicity of the contrast medium or risk
from development of nephrogenic systemic fibrosis, associ-
ated with gadolinium 
11. The gold standard to diagnose RAS
still remains digital-subtraction angiography but it is invasive
diagnostic procedure with risks from different vascular com-
plications.
While the application of percutaneous dilatation is an
effective modality of treatment FMD 
12, optimal therapy of
ARAS is still controversial 
13.
The aim of this case reports was to show the effect of ap-
plying PTRA with stent implantation on renal function in four
patients with significant renal artery stenosis. Under signifi-
cant stenosis we assumed renal artery lumen narrowing greater
than 70%. Two patients had atherosclerotic RAS, one patient
FMD and one patient had renal artery stenosis of transplanted
kidney. In all the patients endovascular intervention led to the
normalization or improvement of renal function.
Case 1
A 57-year-old former smoker, with the history of arte-
rial hypertension, abdominal aneurism and renal insuffi-
ciency was admitted with following signs and symptoms:
shortness of breath, edema and oliguria. Laboratory find-
ings showed an increase in serum creatinine from 230 to
881  ȝmol/L, with normal results of urine. Hemodialysis
treatment was initiated through a central venous catheter. A
total of four procedures was carried out, by means of which
we achieved a good control of blood pressure and de-
creased values of serum creatinine to 365 mmol/L. Ultra-
sound examination revealed the right kidney of reduced
size (8.2 cm), with thin parenchyma (0.7 cm) and without
doppler signal. Left kidney diameter was 11.5 cm, with thin
parenchyma in the upper half of the kidney -0.9 cm, with-
out doppler signal. In the lower half of the left kidney pa-
renchyma was a 1.6 cm and intrarenal doppler examination
showed that the resistive index (RI) was 0,45. Based on
clinical features and the finding of a low RI, the patient was
suspected to having significant stenosis of the left renal ar-
tery. Multislice computed tomography (MSCT) arteriogra-
phy was performed and diagnosed the existence of the scle-
rotic right kidney with an occluded artery, while the left
kidney had two arteries. Artery in the upper half was oc-
cluded and the artery of the lower half had ostial and sub-
total stenosis/narrowing of more than 95% lumen (Figure
1a). By the interventional radiologist the patient underwent
percutaneous transluminal renal angioplasty (PTRA) with
dilation and implantation of a stent size 3 u 18 mm in the
artery to the lower half of his left kidney (Figure 1b). The
achieved response was well and clinically manifested in the
a) b)
Fig. 1 – The case 1: (a) subtotal ostial stenosis of the artery in the lower half of the left kidney before
percutaneous transluminal renal angioplasty (PTRA) and (b) after PTRAVolumen 70, Broj 4 VOJNOSANITETSKI PREGLED Strana 413
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decline of serum creatinine value of 222 Pmol/L at dis-
charge and normalization of blood pressure values, which
with application of antihypertensive medications was
130/70 mmHg. Interventional procedures and time to dis-
charge passed without complications.
Case 2
A 61-year-old smoker was admitted due to worsening
of arterial hypertension with a max. value of blood pressure
up to 180/110 mmHg. Laboratory analysis showed elevated
serum creatinine, which amounted to 121 Pmol/L. Ultra-
sound finding in the kidneys was normal. Intrarenal doppler
obtained the normal value of RI, which in the right kidney
was 0.65, and 0.64 in the left kidney. MSCT angiography
was done. We diagnosed infrarenal localized abdominal
aortic aneurysm and significant stenosis of the left renal
artery to 1.5 cm from the ostium (Figure 2a). The right kid-
ney was vascularized with 2 arteries. The artery for the up-
per half of the right kidney had significant stenosis at 1 cm
from the ostium (Figure 2b). We applied PTRA to the left
renal artery with dilation and implantation of two stents of
the dimension of 6 u 18 mm and obtained an excellent an-
giographic response (Figure 2c). A month following the
previous, we performed PTRA to the significantly nar-
rowed one of the existing two right renal arteries, with di-
lation and implantation of a stent size 3.5 u 18 mm (Figure
2d). Both interventions were performed without complica-
tions. After the treatment, the patient had normal values of
blood pressure and creatinine, which was 93 Pmol/L at dis-
harge.
a) b)
c) d)
Fig. 2 –  The case 2: (a) significant stenosis of the left renal artery before percutaneous transluminal renal angioplasty
(PTRA); (b) significant stenosis of the artery for the upper half of the right kidney before PTRA; (c) the left renal artery after
PTRA; (d) the artery for the upper half of the right kidney after PTRAStrana 414 VOJNOSANITETSKI PREGLED Volumen 70, Broj 4
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Case 3
A 43-year-old patient was admitted due to worsening of
arterial hypertension, with a maximum value of blood pres-
sure 240/130 mmHg and the development of renal insuffi-
ciency with serum creatinine value of 148 Pmol/L. The per-
sonal history showed that the patient had subarachnoid
bleeding in February 2008. Angiographic examination diag-
nosed the presence of an aneurysm of a. communicans cere-
bri anterior. Embolization was done.
Ultrasound examination revealed the right kidney of re-
duced-size (7 cm), with thin parenchyma (0.7 cm) and with-
out doppler signal. The left kidney diameter was 11.2 cm,
normal widh of parenchyma (1.6 cm) and intrarenal doppler
examination showed that the RI was 0.41. Based on clinical
features and the finding of low RI, the patient was suspected
to having significant stenosis of the left renal artery. MSCT
arteriography was performed and diagnosed the existence of
the sclerotic right kidney with the graceful and ocluded right
renal artery (Figure 3a). The left renal artery had numerous
stenosis, with classic “string of beads” appearance (Figure
3b). By the intervention radiologist, the patient underwent
PTRA with three dilations, but there was no satisfactory an-
giographic response, so a stent size 3 u 30 mm was placed
(Figure 3c). Interventional procedure was performed without
complications. At discharge the patient had normal value of
serum creatinine which was 102 Pmol/L and normal blood
pressure of 120/80 mmHg, by applying an antihypertensive
medication.
Case 4
A 37-year-old patient, with living-related kidney trans-
plantation 9 months before, was admitted because of deterio-
ration of the function of renal graft. Laboratory findings
showed an increase in serum creatinine from 130 to 286
Pmol/L, which coincided with the introduction of antihyper-
tensive drugs from the group of ACE inhibitors. The extra
renal doppler examination showed the peak sistolic velocity
of 280 cm/s at the site of anastomosis of the renal and hypo-
gastric artery. We performed percutaneous renal angiography
a) b)
 c)
Fig. 3 – The case 3: (a) ocluded right renal artery;  (b) the left renal artery with the classic “string of beads”
appearance before percutaneous transluminal renal angioplasty (PTRA); (c) the left renal artery after PTRAVolumen 70, Broj 4 VOJNOSANITETSKI PREGLED Strana 415
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and diagnosed the significant (narrowing of 85% lumen of
artery) annular stenosis at the site of anastomosis. Interven-
tional radiologist performed dilation with implantation of a
stent size 5 u 20 mm. After the procedure there was a decline
in serum creatinine, the value of which at discharge was 150
Pmol/L. The patient was regularly controlled and graft func-
tion was stable. In June 2009, due to worsening of blood
pressure, restenosis was suspected. MSCT angiography
showed stent patency, with no signs of stenosis (Figure 4).
Fig. 4 – The Case 4: the renal artery of transplanted kidney
without stenosis
Discussion
The optimal therapeutic treatment of ARAS is still un-
clear. Until now randomized clinical studies comparing the ef-
fects of combined application of balloon angioplasty with stent
implantation and drug therapy as opposed to the application of
drug therapy alone, have shown no significant higher survival
rate of patients in the first group 
14–16. There is an ongoing
largest, multicenter, randomized, controlled clinical trial on
1080 patients, CORAL (Cardiovascular Outcome in Renal
Atherosclerotic Lesions) study, with better defined criteria for
treatment of renal artery stenting, the aim of which is to avoid
shortcomings of previous studies. The results of this study are
expected by the end of 2011. Until completion of the results
the CORAL study, endovascular intervention should be im-
plemented only in patients with tight RAS of the single func-
tioning kidney or with bilateral stenosis in patients with recur-
rent pulmonary oedema or when arterial hypertension is re-
fractory to medication with rapid reduction of renal function.
The presence of a small, sclerotic kidney is an obvious con-
traindication for endovascular intervention 
17.
Two of the patients with atherosclerotic RAS were
older, with signs of generalized atherosclerotic disease, in-
cluding the existence of abdominal aortic aneurysm. In both
patients there were clear indications for implementation of
PTRA and stent implantation. In the first patient there was
significant ostial stenosis of the single functioning kidney,
followed by rapid deterioration of renal function and the de-
velopment of hypervolemia with the signs of heart failure.
Kane et al. 
18 demonstrated that renal artery revascularization
resulted in improved heart failure control and reduction in
the number of hospitalizations. In the patient number 2 there
was significant bilateral renal artery stenosis accompanied by
refractory arterial hypertension and worsening of renal func-
tion. Ischemic damage led to no reduction in kidneys size.
Upon completion of the treatment in both patients there was
an improvement or normalization of renal function, so good
control of blood pressure was achieved.
In contrast to ARAS, FMD is more common in younger
female persons and changes typically occur in the middle or
distal arterial segments 
19. The cause is less than 10% of
cases of renovascular hypertension. In addition to renal ar-
tery, FMD can occur in the cerebral and visceral arteries, and
may clinically manifest as arterial hypertension, stroke, ab-
dominal angina and claudications. The incidence of unrup-
tured intracranial aneurysms in patients with FMD vary
widely, from 7% to more than 50% 
20. Percutaneous balloon
angioplasty is a therapeutic modality of treatment in patients
with poorly regulated arterial hypertension and renal failure.
Stent implantation is applied in the case of obtaining subop-
timal response or dissection of renal artery 
21.
In our patient number 3 the diagnosis of renal artery
FMD was preceded by subarachnoid hemorrhage caused by
rupture of aneurysm a. communicans cerebri anterior. Renal
artery stenosis is clinically manifested by resistant arterial
hypertension and the development of acute renal failure. Al-
though the loss of renal mass occures in up to 63% of pa-
tients with renal-artery FMD, renal failure is rare in these
patients 
22. Occurrence of acute renal failure in our patients
may be partly explained by the existence of a hypoplastic
right kidney. After applying PTRA we obtained a suboptimal
angiographic response, which was the reason for stent im-
plantation. After the treatment the patient achieved normali-
zation of blood pressure and kidney function.
Renal transplant artery stenosis is often an unrecognized
vascular complication that can occur several months and years
after kidney transplantation. The published incidence ranges
from 1% to 23% depending on the criteria used for diagnosis 
23.
It occurs more frequently at the anastomotic site compared with
the distal part of donors artery 
24. Stenosis is usually mani-
fested as difficult-to-treat hypertension, with deterioration of
renal function, in the absence of rejection, recurrence of pri-
mary disease, calcineurins toxicity, infections and ureteral ob-
struction 
25–28. Duplex-Doppler examination is the ideal test for
screening and follow-up of stenosis. Balloon-angioplasty is a
therapeutic method of choice in comparison with surgical re-
vascularization and drug therapy 
29, 30.
In our patient number 4 the graft renal artery stenosis
was diagnosed 9 months after the renal transplantation.
Transplantation was complicated with endarterectomy of hy-
pogastric artery of recipient and thrombosis at the anastomo-
sis. It was the reason to do thrombectomy and reanastomosis.
The above surgical complication probably represented the
predisposing factor for the development of stenosis. Graft
renal artery stenosis manifested with deterioration of itsStrana 416 VOJNOSANITETSKI PREGLED Volumen 70, Broj 4
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function, which coincided with the application of drugs from
the group of ACE inhibitors. Findings obtained by doppler
examination indicated the presence of stenosis at anastomo-
sis. We applied percutaneous selective angiography and con-
firmed the existence of significant annular stenosis of the re-
nal artery at anastomosis. At that time our institution had no
MSCT. After application of PTRA with stent implantation
graft function improved. At outpatient control, the patient
maintained stable graft function 7 years after the transplanta-
tion. The value of creatinine was 124 ȝmol/L at the last am-
bulatory control in June 2011.
Conclusion
In patients with acute or worsening chronic renal insuffi-
ciency, the existence of significant stenosis of one or both re-
nal arteries should be considered. Timely application of PTRA
in these patients leads to preservation of renal function.
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